Procoagulant platelets promote immune evasion in triple-negative breast cancer
Johanna B. Schaubaecher(LMU Klinikum), Christoph A. Reichel(LMU Klinikum), Joshua Luft(Technical University of Munich), Kirsten Lauber(German Cancer Research Center), Wilko Weichert(Deutsches Konsortium für Translationale Krebsforschung), Laura Mittmann(LMU Klinikum), Simone Ballke(Technical University of Munich), Rainer Kaiser(LMU Klinikum), Zhengquan Wu(Ludwig-Maximilians-Universität München), Bernd Uhl(German Cancer Research Center), Gabriele Zuchtriegel(LMU Klinikum), Florian Haring(Ludwig-Maximilians-Universität München), Leo Nicolai(German Centre for Cardiovascular Research), Vera Schneewind(Ludwig-Maximilians-Universität München), Matthias Mack(University Hospital Regensburg), Jonas Hildinger(LMU Klinikum), Shaan Mahameed(LMU Klinikum), Constanze Braun(LMU Klinikum), Katja Steiger(Technical University of Munich), Martin Canis(LMU Klinikum), Bojan Smiljanov(Ludwig-Maximilians-Universität München)
Cited by 33
Related Papers
Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy
|Circulation|2020|570
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
|Radiation Oncology|2019|484
Fungi and inflammatory bowel diseases: Alterations of composition and diversity
|Scandinavian Journal of Gastroenterology|2008|432
Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes
|PLoS Computational Biology|2012|216